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ABStRACt
Objectives: The aim of this work was to investigate the secretor status of patients with oral pre-cancerous and cancerous 
lesions and ABH antigens expression in fixed tissue sections of these patients.
Study design: To reveal A, B and H antigens in tissue sections of patients with precancerous and cancerous oral lesions 
(n= 54) we used a modified specific red cell adherence technique (SRCA-test). Normal endothelial cells expressed ABH 
antigens, the presence of indicator erythrocytes at the lumen of the blood vessels served as a built in positive control. The 
test results were graded from negative adherence to very strongly positive adherence. Negative adherence was defined as 
a complete absence of adhered indicator erythrocytes. A strongly positive reaction was defined as a sheet of indicator 
erythrocytes adhered to the epithelia cells. Results: In 31 of the 54 samples analyzed the test showed slightly positive 
results on atypical areas, and there was a complete antigen deletion in areas histologically affected by neoplasia. Sixteen 
samples showed a total absence of ABH antigens in both histologically normal and pathological areas. As a working 
hypothesis, we propose that areas of SRCA-test negative epithelium are closely related to invasive carcinomas and may be 
their precursor lesions. Further it is suggested that areas of blood group isoantigen negative epithelium showing atypia, 
or in some instances near normal histology, may give rise to relatively low grade carcinomas. Conclusions: Considering 
these results we suggest the use of this method to monitor probable preneoplastic lesions in risk population, specially 
in those with no secretor status.
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IntRoduCtIon
Histo-blood group ABH (O) antigens are the major alloge-
neic antigens in humans and they are widely distributed in 
human tissues. Their presence not only is limited in blood 
cells but also is found in various epithelial cells (1, 2). Since 
most human cancers originate from epithelial cells, changes 
in blood group antigens are an important topic in human 
tumor immunology. Glycolipids constitute an essential part 
of blood group antigens present at the cell surface mem-
branes. In human tumors, blood group antigens change in 
the same general direction as other glycosphingolipids do 
in tumors (3, 4).
Tumor progression is often associated with altered gly-
cosylation of the cell-surface proteins and lipids (5). The 
peripheral part of these cell-surface glycoconjugates often 
carries carbohydrate structures related to the ABO and 
Lewis blood-group antigens. The expression of histo-blood-
group antigens in normal human tissues is dependent on the 
type of differentiation of the epithelium. In most human 
carcinomas, including oral carcinoma, a significant event is 
decreased expression of histo-blood-group antigens A and B 
(6). The mechanisms of aberrant expression of blood-group 
antigens are not clear in all cases. (5-9). It has been demon-
strated in a number of earlier studies on the etiology and 
pathogenesis of certain diseases that the patients’ secretor 
status (ABO (H) blood group antigens) may probably be 
a factor influencing the development of systemic oral dis-
eases (10). This likelihood has prompted the present study, 
to examine the differences in the saliva secretor status by 
comparing patients with oral pre-cancerous and cancerous 
lesions on the one hand, and the healthy population on the 
other; in relation to the ABH antigens expression in fixed 
tissue sections of these patients.
MAtERIALS And MEtHodS
In total 108 subjects were examined, half  of whom suffered 
from oral pre-cancerous and cancerous lesions, while the 
other half  were the healthy control group. All were sub-
jected to clinical oral examinations and standard evaluation 
tests in order to establish the secretor status of their saliva 
(agglutination inhibition technique) (11). In the group of 
patients with oral pre-cancerous and cancerous lesions 
(experimental group), a pathohistological examination of 
the oral mucosa was performed.
• Inhibition test for Secretor Status: (11)
2 or 3 mL. of  saliva were collected into wide mouthed 
tubes. In order to eliminate the mucine protein they were 
treated with thermal shocks. They were centrifuged and 
the supernatant were transferred to a clean test tube and 
placed in boiling water bath for 10 minutes to inactivate 
salivary enzymes. 
To 1 drop of appropriately diluted blood grouping reagent 
(anti-A, anti-B or ulex europeaus) we added 1 drop of pa-
tient’s saliva. We incubated 10 minutes at room temperature 
and then we added 2 drops of 2% to 5% saline suspension 
of washed indicator red cells. Then, the tube was incubated 
30 minutes and centrifuged in order to inspect cell button 
macroscopically for agglutination.
Agglutination of indicator cells by antibody in tubes con-
taining saliva indicates that the saliva does not contain the 
corresponding antigen (non secretor status, se). Failure of 
known antibody to agglutinate indicator cells after incuba-
tion with saliva indicates that the saliva contains the cor-
responding antigen (secretor status, se).
• Specific red cell adherence test (12)
Specific red cell adherence test was performed on paraffin 
embedded sections to detect the intensity of isoantigens A, 
B and H (O) on the epithelial cell surface by a three layer 
sandwich technique. 
Reagents Used 
-. Commercially available antisera, Anti A, Anti B, and Anti 
AB, from span diagnostic limited and lectin ulex europeaus 
(Anti H).
-. Tris Buffer saline 0.05 M with pH 7.4.
-. 2-5% Red Blood Cell’s suspension.
• Procedure in Brief
Slides of 4-5 micron section were deparaffinized and brought 
to water, immersed in tris buffered saline 0.05 M (pH 7.4) 
for 30 minutes, covered with isologous antisera according 
to patients’ blood group and incubated for one hour for A, 
B and O group in a most chamber at room temperature. 
The slides were then dipped in tris buffered saline for three 
changes with occasional strings to remove the unreacted 
antisera. Few drops of  2-5% isologous indicator RBC’s 
suspension were added to the sections and incubated for 
20 minutes in group A or B and one hour for group O. The 
slides were inverted over a support in a petridish containing 
tris buffered saline such that the undersurface of the slide 
just touched the solution and kept for five minutes to settle 
down unreacted RBCs. The slides were observed under low 
power and photographed immediately.
Controls: Normal tissues containing blood group antigens, 
endothelium of blood vessels and RBCs acted as inbuilt 
positive controls and adipose tissues acted as inbuilt nega-
tive controls.
Interpretation:
In the present study the isoantigenicity of epithelium was 
graded according to degree of adherence of indicator RBCs 
as strongly positive adherence (++++) to negative adher-
ence (-), Levels intermediate were determined as 25% of 
adherence +, 50% of adherence ++ and 75% of adherence 
+++.
StAtIStICAL AnALySIS 
The categorical data were examined with a χ2 test, and 
the ORs were estimated using an unconditional logistic 
model. 
RESuLtS
The 79.5 % of the healthy individuals studied posses the 
Se gene that governs the secretion of water-soluble ABH 
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antigens into saliva (secretor status). These secreted antigens 
can be demonstrated in saliva by agglutination inhibition 
tests with ABH antisera. The 51% (n=16) of the patients 
with oral pre-cancerous and cancerous lesions was non 
secretors (se), RO = 2.44; IC 95% (0.7836 ; 7.5534) (p= 
0.1196) in contrast with the healthy population (Table 1), 
We observed a marginal association between secretor status 
(Se) and these lesions. 
The immunoadherence reaction to tissue sections using 
antibodies and red blood cells showed a loss of A, B or H 
antigens related to the stage of tumor (Table 2). We found 
a higher intensity of oral disease in the non secretor group 
(se), RO = 3.44; IC95% (1.0682; 11.0729) (p= 0.0346), and 
the occurrence of epithelial dysplasia was found exclusively 
in these group.
A loss of ABH reactivity within the most invasive sites of 
the tumors correlated significantly with the stage of tumor 
development and histological grade of malignancy. 
In the sections tissue studied the endothelium of  blood 
vessels was reactive with the erythrocytes (positive control) 
and adipose tissues did not react with the red blood cells 
(negative controls).
dISCuSSIon
The membrane, which defines the extent of the cell, is not 
only a physical boundary but also has many specific func-
tions, among which is the capacity to react with other cells 
and the intracellular matrix (13, 14). Carbohydrates are 
structures found on the cell surface bound to either lipid 
or protein embedded in the membrane. Changes in the 
carbohydrate structure of these cell-surface glycolipids and 
glycoproteins have been demonstrated during development, 
during cell maturation in adult tissue, and in relationship 
to malignant development (9,15,16,17)  
Most studies concerning the tissue localization of  the 
histo-blood-group antigens have shown that the antigens 
in the tissues correspond to the erythrocyte blood group, 
but that the tissue expression is dependent on the secretor 
status of the individual (14). Furthermore, the expression 
of histo-blood-group antigens in normal human tissues is 
dependent on the type of differentiation of the epithelium 
and the degree of maturation of the single cell within the 
epithelium. In stratified epithelium, the expression of 
histo-blood-group antigens depends on the state of  cel-
lular differentiation (maturation), and there is a sequential 
elongation of the terminal carbohydrate chain during the 
life span of the cell. Basal cells express short carbohydrate 
chains that are A/B precursors, whereas A, B or H antigens 
may be seen in the spinous cell layer.
The results obtained have demonstrated that the large major-
ity of the people examined in the healthy group were Se and 
there were significant difference between secretors and non-
secretors in the experimental group. We also found a higher 
intensity of oral disease in the se group, and the occurrence 
of epithelial dysplasia was most found in these group.
The studies of patients with pre malignant and malignant 
oral lesions in which non-secretor status predominates, ap-
pear to be an associated risk marker for the development 
for oral cancer. 
We also observed a reduction or complete deletion of A, 
B or H antigen expression in sections of tissues of patients 
se with oral pre carcinomas or carcinomas. Disappear-
ance of the antigens is ascribed to the absence of A or B 
transferase gene expression. These findings are consistent 
with several studies showing that loss of A and B antigen 
expression is associated with increased tumourigenecity in 
syngeneic animals.
In summary, our results indicate that at the same time as 
the morphological changes that occur during the process of 
oral carcinogenesis, another series of events occurs. Further 
follow-up studies are required to clarify the role of predictive 
markers of risk in precursor lesions of oral cancer. 
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Secretor Status 16 15 
Non Secretor Status 7 16 
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(Se) 
Non secretor 
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table 2. ABH antigens expression in fixed tissue sections of oral 
lesions
table 1. Salivary secretor status in patients with oral lesions.
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